Chemed Shareholders Seeking to Recover Losses through Investor Lawsuit Encouraged to Contact Securities Lawyers at Deans & Lyons LLP PR Newswire DALLAS, May 30, 2013 DALLAS, May 30, 2013 /PRNewswire/ -- Securities lawyers are investigating Chemed (NYSE: CHE) due to potential violations of shareholder protection laws. Concerned CHE stockholders who seek to recover value for their shares should contact securities lawyer Hamilton Lindley at 877-819-8033 or email@example.com about potential investor claims. Securities lawyers are investigating the company due to a False Claims Act complaint filed by the U.S. Government. The allegations in that lawsuit involve billing Medicare for unnecessary crisis care services and admitting patients who were not eligible for the Medicare hospice benefit. On news of this lawsuit, Chemed stock price dropped precipitously. Deans & Lyons LLP has significant experience representing investors in securities class action and derivative lawsuits nationwide. Stockholders with concerns about their CHE stock or anyone with information about this situation should contact Hamilton Lindley at firstname.lastname@example.org or 877-819-8033. Hamilton Lindley Deans & Lyons LLP 325 N. Saint Paul Street, Suite 1500 Dallas, TX 75201 (877) 819-8033 Toll Free (214) 965-8500 Telephone (214) 965-8505 Facsimile email@example.com deanslyons.com SOURCE Deans & Lyons LLP Website: HTTP://www.deanslyons.com
Chemed Shareholders Seeking to Recover Losses through Investor Lawsuit Encouraged to Contact Securities Lawyers at Deans & Lyons
Press spacebar to pause and continue. Press esc to stop.